Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 241.44 USD 1.14% Market Closed
Market Cap: 20.2B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Laboratory Corporation of America Holdings
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Laboratory Corporation of America Holdings
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Laboratory Corporation of America Holdings
NYSE:LH
Total Liabilities & Equity
$18.6B
CAGR 3-Years
-4%
CAGR 5-Years
1%
CAGR 10-Years
10%
DaVita Inc
NYSE:DVA
Total Liabilities & Equity
$17.5B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Chemed Corp
NYSE:CHE
Total Liabilities & Equity
$1.8B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
7%
Quest Diagnostics Inc
NYSE:DGX
Total Liabilities & Equity
$16.1B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Total Liabilities & Equity
$252.4B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
13%
Cigna Corp
NYSE:CI
Total Liabilities & Equity
$157.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
11%
No Stocks Found

Laboratory Corporation of America Holdings
Glance View

Market Cap
20.2B USD
Industry
Health Care
Economic Moat
None

Laboratory Corporation of America Holdings, commonly referred to as LabCorp, has established itself as a leader in the biomedical testing and diagnostics industry. Founded in 1971, the company operates with a mission to improve health and improve lives by providing critical laboratory services to healthcare providers, pharmaceutical companies, and patients. LabCorp offers a comprehensive range of tests, encompassing everything from routine blood work to complex genomic testing. This diverse portfolio positions LabCorp to benefit from the growing demand for diagnostic services, particularly as healthcare continues to evolve toward precision medicine and personalized care. For investors, LabCorp's strategic initiatives and strong financial performance paint a compelling picture. The company has successfully expanded through a series of acquisitions, enhancing its capabilities and market reach. With a focus on innovation, LabCorp has invested heavily in advanced technologies and digital solutions to streamline operations and enhance customer experience. As the healthcare landscape shifts toward value-based care, LabCorp is well-positioned to capture market share and drive revenue growth. With a history of consistent earnings and a commitment to shareholder value, LabCorp represents a potentially attractive investment for those looking to engage in the evolving healthcare sector.

LH Intrinsic Value
262.06 USD
Undervaluation 8%
Intrinsic Value
Price

See Also

What is Laboratory Corporation of America Holdings's Total Liabilities & Equity?
Total Liabilities & Equity
18.6B USD

Based on the financial report for Sep 30, 2024, Laboratory Corporation of America Holdings's Total Liabilities & Equity amounts to 18.6B USD.

What is Laboratory Corporation of America Holdings's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
10%

Over the last year, the Total Liabilities & Equity growth was 10%. The average annual Total Liabilities & Equity growth rates for Laboratory Corporation of America Holdings have been -4% over the past three years , 1% over the past five years , and 10% over the past ten years .

Back to Top